Use of cyclophosphamide and other immunosuppressive drugs in the treatment of patients with lupus nephritis

Author： Brugos B.   Sebestyen L.   Tarr T.   Vincze Z.  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.6, 2014-06, pp. : 442-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Newer Drugs for the Treatment of Lupus Nephritis

By Kuiper-Geertsma D.G.  

Drugs, Vol. 63, Iss. 2, 2003-01 ,pp. : 167-180

Adis International

Access to resources Recommend Favorite

MMF surpasses cyclophosphamide in lupus nephritis

By  

Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Low- vs high-dose cyclophosphamide in lupus nephritis

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Cyclophosphamide: Miscarriage in patients with lupus nephritis?: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1365, 2011-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Low-dose fludarabine plus cyclophosphamide is effective in patients with proliferative lupus nephritis, but is associated with considerable adverse outcomes

By  

Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite